Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
about
The anticancer drug ellipticine activated with cytochrome P450 mediates DNA damage determining its pharmacological efficiencies: studies with rats, Hepatic Cytochrome P450 Reductase Null (HRN™) mice and pure enzymes.The collective nuclear migration of p53 and phosphorylated S473 of Akt during ellipticine-mediated apoptosis in human lung epithelial cancer cells.Psoralen with ultraviolet A-induced apoptosis of cutaneous lymphoma cell lines is augmented by type I interferons via the JAK1-STAT1 pathway.
P2860
Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
@en
type
label
Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
@en
prefLabel
Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
@en
P2860
P50
P1433
P1476
Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
@en
P2093
Cecilia Savorani
Valentina Manfé
P2860
P304
P356
10.3109/10428194.2014.929673
P577
2014-08-04T00:00:00Z